R. Analyse-des, 23 3.2.1 Evolution de la fonction rénale après arrêt des, 24 3.2.3 Evolution de la kaliémie après arrêt du traitement, p.24

K. Akposso, A. Hertig, R. Couprie, A. Flahaut, C. Alberti et al., Acute renal failure in patients over 80 years old: 25-years' experience, Intensive Care Medicine, vol.26, issue.4, p.4006, 2000.
DOI : 10.1007/s001340051173

R. Kunz, C. Friedrich, M. Wolbers, and J. Mann, Meta-analysis: Effect of Monotherapy and Combination Therapy with Inhibitors of the Renin???Angiotensin System on Proteinuria in Renal Disease, Annals of Internal Medicine, vol.148, issue.1, p.3048, 2008.
DOI : 10.7326/0003-4819-148-1-200801010-00190

S. Björck, G. Nyberg, H. Mulec, G. Granerus, H. Herlitz et al., Beneficial effects of angiotensin converting enzyme inhibition on renal function in patients with diabetic nephropathy Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia), Br Med J Clin Res Ed. 23 août Lancet Lond Engl. 28 juin, vol.293349, issue.65459069, pp.4714-9185763, 1986.

Y. Lee, S. Cho, S. Kim, H. Jang, J. Lee et al., Effect of losartan on proteinuria and urinary angiotensinogen excretion in non-diabetic patients with chronic kidney disease Recommandations pour la pratique clinique -Moyens thérapeutiques pour ralentir la progression de l'insuffisance rénale chronique chez l'adulte, disponible sur, Postgrad Med J. oct, vol.87, issue.11, p.6649, 1032.

L. Tylicki, A. Jakubowska, S. Lizakowski, D. ?wietlik, and B. Rutkowski, Management of renin-angiotensin system blockade in patients with chronic kidney disease under specialist care. Retrospective cross-sectional study, Journal of the Renin-Angiotensin-Aldosterone System, vol.13, issue.1, p.14552, 2015.
DOI : 10.1016/S0140-6736(08)61236-2

M. Yamamoto, M. Fukui, I. Shou, L. Wang, K. Sekizuka et al., Effects of treatment with angiotensin-converting enzyme inhibitor (ACEI) or angiotensin II receptor antagonist (AIIRA) on renal function and glomerular injury in subtotal nephrectomized rats, Journal of Clinical Laboratory Analysis, vol.45, issue.1, p.5362, 1997.
DOI : 10.1002/(SICI)1098-2825(1997)11:1<53::AID-JCLA9>3.0.CO;2-L

K. Griffin, A. Bidani, P. Cravedi, and G. Remuzzi, Progression of renal disease: renoprotective specificity of renin-angiotensin system blockade The role of renin angiotensin system inhibition in kidney repair, Clin J Am Soc Nephrol CJASN. sept Fibrogenesis Tissue Repair. 4 mai, vol.13, issue.5, p.7, 2006.

A. Ahmed, N. Kamath, M. Kossi, and A. Nahas, The impact of stopping inhibitors of the renin-angiotensin system in patients with advanced chronic kidney disease, Nephrology Dialysis Transplantation, vol.25, issue.12, p.397782, 2010.
DOI : 10.1093/ndt/gfp511

G. Remuzzi, N. Perico, M. Macia, and P. Ruggenenti, The role of renin-angiotensinaldosterone system in the progression of chronic kidney disease, Kidney Int déc, issue.99, pp.57-65, 2005.

M. Rainfray, S. Richard-harston, N. Salles-montaudon, and J. Emeriau, [Effects of aging on kidney function and implications for medical practice]. Presse Médicale Paris Fr 1983, juill, vol.29, issue.24, p.13738, 2000.

M. Laville, R. N. Le, H. Whitaker, C. Farrington, B. Spiessens et al., Stoermann-Chopard C. Fonction rénale et vieillissement du rein Etat des lieux -Niveau de preuve et gradation des recommandations de bonne pratique, disponible sur: http://www.has-sante.fr/portail/upload/docs/application/pdf/2013- 06/etat_des_lieux_niveau_preuve_gradation.pdf 22 Tutorial in biostatistics: the self-controlled case series method Insee -Population -Bilan démographique 2015 -Population totale par sexe et âge, Médecine Hygiène, vol.205825, issue.23, pp.4235-21176897, 2000.

N. Kagiyama, R. Uozumi, K. Odashima, K. Kurashima, and S. Morita, prognostic factors for survival in non-small cell lung cancer: a comprehensive analysis of 26,957 patients with NSCLC Risk factors for the severity and mortality of pneumococcal pneumonia: Importance of premorbid patients' performance status, Performance status and smoking status are independent favorable, p.68591, 2010.

G. Bobrie, A. Chedid, P. Rossignol, and P. P. , Adaptation du traitement par IEC et ARAII chez l'insuffisant cardiaque en fonction de la créatininémie et de la kaliémie, disponible sur: http://www.realites-cardiologiques.com/wp-content/uploads, 2011.

S. Jones, B. Sautenet, C. Barbet, M. Büchler, F. Bruyère et al., ):2436. 30 Infections urinaires et antibiothérapie chez l'insuffisant rénal Septic acute kidney injury in critically ill patients: clinical characteristics and outcomes Guide du parcours de soins -Maladie Rénale Chronique de l'adulte, disponible sur: http://www.has-sante.fr/portail/upload/docs/application/pdf/2012- 04/guide_parcours_de_soins_mrc_web.pdf 33. Texte court du rapport d'évaluation technologique -Evaluation du rapport albuminurie/créatininurie dans le diagnostic de la maladie rénale chronique chez l'adulte, disponible sur: http://www.has-sante.fr/portail Acute kidney injury classification: comparison of AKIN and RIFLE criteria Diagnostic de l'insuffisance rénale chronique : Estimer le débit de filtration glomérulaire par l'équation CKD-EPI, F859. 31, pp.4319-3224752, 1992.

M. Gault, C. New, A. Castro, and H. Feldman, Formulas in Relation to GFR, Age, and Body Size A New Equation to Estimate Glomerular Filtration Rate, Clin J Am Soc Nephrol CJASN. juin Ann Intern Med. 5 mai, vol.5150, issue.69, p.60412, 2009.

É. Moing, Prévention de l'insuffisance rénale aiguë par l'optimisation de la prise des médicaments inhibiteurs du système rénine angiotensine et aldostérone et des diurétiques, 2016.

É. A. Agbonon, C. Delcroix, M. Moutel, and J. Nguyen, Analyse de la prévisibilité de l'insuffisance rénale aiguë chez les patients sous bloqueurs du système rénine angiotensine aldostérone et / ou diurétiques : quelle place pour le médecin traitant ? 8 janv 2015 Diuretic and enhanced sodium restriction results in improved antiproteinuric response to RAS blocking agents, J Am Soc Nephrol JASN. févr, vol.7516, issue.2, p.47481, 2005.

P. Ruggenenti, A. Perna, G. Remuzzi, G. Maschio, D. Alberti et al., Ramipril in non-diabetic renal failure (REIN study) The Lancet Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group, N Engl J Med, vol.350334, issue.907915, pp.7367-4293945, 1996.

N. Morel, P. Hausfater, M. Bendahou, S. Delerme, P. Ray et al., Fréquence et prise en charge de l'hypotension orthostatique chez le sujet âgé aux urgencesA148. 44. Burns J. Patient safety and hydration in the care of older people Effects of suspending ACE inhibitors and ARBs in advanced chronic kidney disease, 214. 45. Díaz-Domínguez ME, p.4001, 2008.
DOI : 10.1016/j.jeur.2008.03.054

K. Woodhouse, P. Farrow, R. Wilkinson, R. Perkins, I. Bucaloiu et al., Reversible renal failure during treatment with captopril GFR Decline and Mortality Risk among Patients with Chronic Kidney Disease Rapid Kidney Function Decline and Mortality Risk in Older Adults, Br Med J. 3 nov Clin J Am Soc Nephrol CJASN. août Arch Intern Med. 10 nov, vol.26168, issue.6198820, pp.11467-47187986, 1979.

L. Sargento, A. Simões, S. Longo, N. Lousada, D. Reis et al., Treatment with Optimal Dose Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers Has a Positive Effect on Long-Term Survival in Older Individuals (Aged >70 Years) and Octogenarians with Systolic Heart Failure Points critiques du parcours de soins -Insuffisance Cardiaque, disponible sur, Drugs Aging. 27 août, vol.50, 2016.